Clinical Trial Update: A Study of Patients With HER2-Positive Metastatic Breast Cancer

View source ↗

Summary

This entry notes the completion of a clinical trial evaluating treatment in patients with HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Genentech, Inc. | Conditions: Breast Cancer | Status: COMPLETED